Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Neotigason

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Objective: We investigated induction of α-secretase A disintegrin and metalloprotease 10 (ADAM10) by the synthetic retinoid… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
2011
2011
Dear Editor, Erythrokeratodermia variabilis (EKV) is a rare genetic disease which is characterized by the coexistence of… Expand
2006
2006
Interferon-α combined with retinoid or PUVA is used for the treatment of cutaneous T-cell lymphoma. Anti-IFN-α antibodies (IFN ab… Expand
  • table 1
  • table 2
1998
1998
Acitretin (Ro 10–1670 or Neotigason), a free acid and the main metabolite of etretinate (Ro 10–9359 or Tigason), is the most… Expand
1997
1997
Acitretin (Ro 10‐1670, Neotigason), a second‐generation monoaromatic retinoid, is the main acid derivative and active metabolite… Expand
1991
1991
A reliable analytical method has been developed for measurement of 13-cis- and all-trans-acitretin (Neotigason) in human plasma… Expand
1990
1990
A high-performance liquid chromatographic procedure is described for the simultaneous determination of etretinate (Tigason), all… Expand
1989
1989
Developmental toxicity of the anti-psoriatic drug etretinate (Tegison) and some features of its metabolic conversion to etretin… Expand